Immediate Impact
1 by Nobel laureates 3 from Science/Nature 61 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Athalia R. Pyzer being referenced
Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Athalia R. Pyzer | 177 | 197 | 31 | 153 | 23 | 382 | |
| Andrea N. Marcogliese | 184 | 112 | 10 | 157 | 23 | 372 | |
| Yoshinori Nonomura | 160 | 185 | 16 | 89 | 24 | 433 | |
| Patricia Tsao | 113 | 152 | 22 | 130 | 15 | 398 | |
| Hao Wu | 68 | 327 | 31 | 100 | 21 | 456 | |
| Mirco Compagnone | 224 | 110 | 42 | 284 | 23 | 451 | |
| Gabriel Brisou | 96 | 260 | 38 | 122 | 20 | 395 | |
| Fani Kalala | 90 | 175 | 25 | 74 | 28 | 337 | |
| Massimiliano De Bortoli | 143 | 94 | 8 | 179 | 19 | 403 | |
| Bo Yu | 197 | 67 | 11 | 168 | 22 | 444 | |
| Laura Bergamaschi | 48 | 208 | 48 | 180 | 15 | 413 |
All Works
Login with ORCID to disown or claim papers
Loading papers...